EXTON, Pa.--(BUSINESS WIRE)--Fibrocell Science, Inc. (OTCBB:FCSC.OB), a cell therapy company focused on the development of autologous (personalized) cell therapies for aesthetic, medical and scientific applications, announced today that LAVIVTM (azficel-T) has been named a 2011 Allure Breakthrough Award winner. LAVIV is a revolutionary new treatment for “smile line” wrinkles made from a person’s own skin cells that was recently FDA-approved.
